相关实验视频
Updated: Jun 25, 2025

07:42
Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
81.3K
骨髓性恶性瘤中的染色体.
1Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan. chienyuanchen@ntu.edu.tw.
Annals of hematology
|May 30, 2024
概括
染色体,一种主要的基因组重组,发生在各种癌症中,如急性髓性白血病 (AML). 染色体的患者往往面临较差的预后和较低的缓解率,需要进一步的研究.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 血液学 血液学 血液学
背景情况:
- 染色体囊症在一次灾难性事件中涉及大量的基因组重组.
- 它在各种恶性瘤中被观察到,包括急性髓性白血病 (AML) 和骨髓质综合征 (MDS).
- 发病率根据恶性瘤类型和特定的遗传突变,如TP53.3,有很大的差异.
研究的目的:
- 总结了发生率,相关的遗传因素,和临床含义的染色体在骨髓性恶性瘤.
- 为了突出染色体的预后影响治疗反应和生存率.
主要方法:
- 对AML和MDS中染色体的现有文献的审查.
- 对报告的发病率,遗传关联 (例如TP53,ERG,FLT3,NPM1) 和临床结果的分析.
主要成果:
- 染色体的发病率范围很广:在AML中为0-6.6%,在复杂型AML中为27.3-100%,在AML中具有TP53突变的AML中为11.1-90%.
- 与复杂的型,TP53突变和单体型相关;ERG放大频繁,MYC放大不常见.
- 与FLT3和NPM1突变负相关;通常发生在老年AML患者中,白细胞和血清数量低.
- 与预后不佳有关,包括较低的完全缓解率和较差的骨髓性恶性瘤的整体存活率.
- 信号通路涉及瘤基因上调和瘤抑制剂下调.
结论:
- 染色体与骨髓瘤恶性瘤的不良结果有关.
- 进一步的大规模研究至关重要,以了解其原因并开发有针对性的治疗方法.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Separation of Sister Chromatids
3.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K

